COMMUNIQUÉS West-GlobeNewswire

BioRestorative Therapies Announces Completion of BRTX-100 Phase 2 Manufacturing, Highlighting Integrated Regenerative Biologics Platform
25/06/2026
MELVILLE, N.Y., June 25, 2026 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc . (“BioRestorative,” “BRTX,” or the “Company”) (Nasdaq: BRTX ) , a late-stage clinical regenerative medicine company focused on stem cell- [...]
Provectus Biopharmaceuticals Launches Veripure™, an Open Science Program for Medical Research Access to PV-10 (rose bengal sodium)
25/06/2026
Under Veripure, Provectus is supplying qualified medical researchers with the same pharmaceutical grade rose bengal sodium API used in clinical trials. Veripure is also a quality benchmark, distinguishing program- [...]
Glass House Brands Announces Uplist to NYSE
25/06/2026
LONG BEACH, Calif. and TORONTO, June 25, 2026 (GLOBE NEWSWIRE) -- Glass House Brands Inc. ("Glass House" or the “Company”) (CBOE CA: GLAS.A.U) (OTCQX: GLASF) today announced that its subordinate voting shares (the “ [...]
The LaVie Institute Introduces Less-Invasive Breast Augmentation Technique with Rapid Recovery
25/06/2026
New muscle-preserving technique is designed to help eligible patients resume work, family responsibilities, and daily activities in days rather than weeks DENVER, June 25, 2026 (GLOBE NEWSWIRE) -- The LaVie Institute [...]
Helus Pharma™ Announces Closing of US$50 Million Underwritten Offering
25/06/2026
NEW YORK and TORONTO, June 25, 2026 (GLOBE NEWSWIRE) -- Helus Pharma™ (Nasdaq: HELP) (Cboe CA: HELP) (the “ Company ” or “ Helus Pharma ”), a clinical stage pharmaceutical company committed to helping minds heal by [...]
Vaxart Announces Update to BARDA Funding Award to Reflect Current Scope of COVID-19 Oral Pill Vaccine Trial
25/06/2026
Latest Modification is Important Required Step to Releasing 12-month Data from 400-participant Sentinel Cohort Funding to Advance Data Analysis from More Than 5,000 Trial Participants Ahead of Key Trial Results SOUTH [...]
TRUE-See Selected to Participate in Microsoft for Start-Ups Azure AI Program to Accelerate Innovation and Growth
25/06/2026
Includes $350,000 in non-dilutive Microsoft Azure AI credits for TRUE-See’s R&D that is incorporating AI to increase the utility and diagnostic accuracy of medical photography TRUE-See’s unique patented technology [...]
Nanox Announces First Quarter 2026 Financial Results and Provides Business Updates
25/06/2026
Management to host conference call and webcast on Thursday, June 25, 2026 at 8:30 AM ET PETACH TIKVA, Israel, June 25, 2026 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD (NASDAQ: NNOX) (“ Nanox ” or the “ Company ”), an [...]
NIMA and RA Capital Launch First-of-Its-Kind Workplace Pilot to Support Employees with Celiac Disease
25/06/2026
New benefit program provides NIMA’s portable gluten sensors at no cost to help employees and their families navigate gluten-free living with greater confidence. BOSTON, June 25, 2026 (GLOBE NEWSWIRE) -- NIMA Partners, [...]
Atea Pharmaceuticals Completes Patient Enrollment in Phase 3 C-FORWARD Trial Evaluating Bemnifosbuvir and Ruzasvir for Treatment of Hepatitis C Virus
25/06/2026
Topline Phase 3 Results from C-FORWARD Expected Around Year-End 2026 More Than 880 HCV Treatment-Naïve Patients Enrolled Across 17 Countries Outside North America C-FORWARD and C-BEYOND Represent the First Global Phase [...]
Vivani Medical Receives Regulatory Approval for the Initiation of SLIM-1, a Phase 1 Clinical Trial of NPM-139 Semaglutide Implant in Obesity and Chronic Weight Management
25/06/2026
ALAMEDA, Calif., June 25, 2026 (GLOBE NEWSWIRE) -- Vivani Medical, Inc. (Nasdaq: VANI) (“Vivani” or the “Company”), a clinical-stage biopharmaceutical company developing miniature, ultra long-acting drug implants, [...]
Canadian Red Cross and Walmart Canada launch annual giving campaign
25/06/2026
Funds raised support disaster relief in communities across Canada OTTAWA, June 25, 2026 (GLOBE NEWSWIRE) -- As Canadians face an active start to the wildfire season and communities continue to recover from recent floods [...]
La Croix-Rouge canadienne et Walmart Canada donnent le coup d’envoi à la campagne de financement annuelle
25/06/2026
Les fonds recueillis permettront d’aider les communautés partout au Canada lors de situations d’urgence OTTAWA, 25 juin 2026 (GLOBE NEWSWIRE) -- Alors que le Canada connaît un début de saison des feux de forêt occupé et [...]
New PerfectServe Research: 85% of Healthcare Leaders Want to Switch Their Contact Center Vendors, But Most Feel Trapped
25/06/2026
Survey of 105 IT and operational leaders reveals tech fragmentation that harms patient experience and complicates operators’ working environment MIAMI, June 25, 2026 (GLOBE NEWSWIRE) -- PerfectServe ® , a leading [...]
Ernexa Therapeutics Launches CEO Corner to Provide Deeper Insights into Company Progress, Scientific Strategy and Vision for Patients
25/06/2026
New platform provides additional perspective on Ernexa's mission to deliver hope for patients through innovative, scalable cell therapies while improving accessibility and affordability Inaugural video highlights [...]
Conexeu Sciences Opens Vancouver R&D Facility to Advance Regenerative Tissue Platform
25/06/2026
Nasdaq-Listed Biotech Pioneer Among the First Companies to Operate at adMare's New M4 Innovation Centre RENO, Nev., June 25, 2026 (GLOBE NEWSWIRE) -- Conexeu Sciences Inc. (Nasdaq: CNXU) (“ Conexeu” or the “Company”), a [...]
Eliaz Therapeutics Highlights Selective Galectin-3 Removal in Sepsis, Advances XGAL-3® Program
25/06/2026
Santa Rosa, United States, June 25, 2026 (GLOBE NEWSWIRE) -- Eliaz Therapeutics Announces Publication Highlighting Selective Galectin-3 Removal Approach in Sepsis and Advancement of XGAL-3 Development Program Company [...]
Data Presented on Two-Year Proximal Neck Dynamics from First-in-Human Study of Abdominal Aortic Aneurysm Treatment
25/06/2026
TEMPE, Ariz., June 25, 2026 (GLOBE NEWSWIRE) -- Nectero Therapeutics announced today a first-in-human (FIH) multicenter study evaluated treatment of small- to medium-sized abdominal aortic aneurysms (AAA) with [...]
BriaCell Partners with Uneedle for Scalable Microneedle Administration of Bria-IMT™
25/06/2026
Agreement supports potential commercial readiness for Bria-IMT using Uneedle’s proprietary microneedle technology for intradermal administration Technology is currently used in BriaCell’s pivotal Phase 3 study and is [...]

Pages